Drug Database
Back to search

United States· US:65841-768_31419037-52ae-41bb-a03e-8965205ab347

Zolmitriptan

A zolmitriptan product containing zolmitriptan, registered in United States by Zydus Lifesciences Limited. The same ATC class is registered in 16 of our 19 countries.

ATC N02CC03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedZolmitriptanATCN02CC03REGISTER NO.US:65841-768_31419037…PACKS LISTED12CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about zolmitriptanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Zolmitriptan is registered in 16 of 19 countries.

Countries holding a registration under ATC N02CC03 (zolmitriptan), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose
Search zolmitriptan products by name

Zolmitriptan · ATC N02CC03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of zolmitriptan costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $1.05 in France to $7.21 in Switzerland — a ×6.9 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Zolmitriptan · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$7.21
  • IT Italy$2.58
  • FR France$1.05
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ZOLMITRIPTAN
Manufacturer
Zydus Lifesciences Limited
Country
United States (US)
ATC code
N02CC03
ATC class
Zolmitriptan
Defined daily dose
2.5 mg, N
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 12

  • ndc11
    65841-768-01
  • ndc11
    65841-768-06
  • ndc11
    65841-768-10
  • ndc11
    65841-768-77
  • ndc11
    65841-768-82
  • ndc11
    65841-768-16
  • ndc11
    6584176801
    100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65841-768-01)
  • ndc11
    6584176806
    30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65841-768-06)
  • ndc11
    6584176810
    1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65841-768-10)
  • ndc11
    6584176816
    90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65841-768-16)
  • ndc11
    6584176877
    10 BLISTER PACK in 1 CARTON (65841-768-77) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65841-768-30)
  • ndc11
    6584176882
    1 BLISTER PACK in 1 CARTON (65841-768-82) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65841-768-87)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

114 interactions on record for zolmitriptan.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check zolmitriptan against other medicinesHow interaction checks work

Zolmitriptan · interactions on record

114 records

  • 11 severe
  • 25 moderate
  • 5 minor
  • 72 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Zolmitriptan in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zolmitriptan products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Aurasin Akut Stada, Zolmitriptan 1a Pharma
  • Belgium · Zolmitriptan Instant Eg, Zolmitriptan Odis Viatris
  • Cyprus · Zomig
  • Czechia · Zolmitriptan Teva
  • Germany · Ascotop, Ascotop Nasal
  • Denmark · Zolmitriptan ”holsten”, Zolmitriptan Holsten
  • Spain · Zolmitriptán Flas Cinfa, Zolmitriptán Flas Combix
  • Finland · Zolmistad, Zolmitriptan Sandoz
  • France · Zolmitriptan Arrow Generiques, Zolmitriptan Biogaran
  • United Kingdom (Northern Ireland) · Zolmitriptan, Zolmitriptan Accord-Uk
  • Croatia · Zelmykra, Zomig
  • Ireland · Zolmitriptan Accord Healthcare Ireland, Zomig
  • Italy · Headzol, Zolmitriptan Aurobindo
  • Luxembourg · Zolmitriptan Instant Eg, Zolmitriptan Viatris
  • Netherlands · Zolmitriptan Disper Aurobindo, Zolmitriptan Glenmark
  • Norway · Zolmitriptan Sandoz, Zomig
  • Poland · Zolmiles
  • Portugal · Zolmitriptano Aurovitas, Zolmitriptano Ciclum
  • Sweden · Zolmitriptan, Zolmitriptan Holsten

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fadc4122-d237-47de-8bd4-62ecab4cbf6a
GET /v1/drugs/fadc4122-d237-47de-8bd4-62ecab4cbf6a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "5",
  "substance": "ZOLMITRIPTAN",
  "productndc": "65841-768",
  "dosage_form": "TABLET, ORALLY DISINTEGRATING",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA202890",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about zolmitriptan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console